Management of no-reflow: Still an unsolved problem?

Alessandro Mandurino-Mirizzi,

Abstract

No-reflow represents an important limitation of percutaneous coronary intervention in patients with ST-elevation myocardial infarction. Importantly, no-reflow is associated with an increased risk of major adverse cardiac events. In this review, we discuss the pharmacological and nonpharmacological interventions proposed for the prevention and treatment of no-reflow, highlighting the new updates and evidences on efficacy of these approaches.

Relevant Publications in Journal of Phlebology and Lymphology